NEXANIB 200 MG
 Nexanib Tablet Sorafenib Tosylate 200 mg Julphar Bangladesh Ltd. Indications Hepatocellular Carcinoma: Sorafenib is indicated for the treatment of patients with
NEXATAF 25 MG
 Nexataf Tablet Tenofovir Alafenamide 25 mg Everest Pharmaceuticals Ltd. Indications Tenofovir Alafenamide is a hepatitis B virus (HBV) nucleoside analog reverse
NIRANIB 100 MG
DESCRIPTION Niranib Niraparib 100 mg Everest Pharmaceuticals Ltd. Bangladesh COMPOSITION NIRANIB Capsule: Each capsule contains Niraparib Tosylate Monohydrate INN equivalent
OBELIVA 10 MG
 Obeliva Tablet Obeticholic Acid 5 mg Everest Pharmaceuticals Ltd. 10 mg Indications Obeticholic Acid is indicated for the treatment of primary
OBELIVA 5 MG
 Obeliva Tablet Obeticholic Acid 5 mg Everest Pharmaceuticals Ltd. 10 mg Indications Obeticholic Acid is indicated for the treatment of primary
OBETIX 5 MG
DESCRIPTION Product Description: Obetix is the only choice for Primary Biliary Cirrhosis (PBC) with the combination of UDCA (Ursodeoxycholic Acid)
OLANIB 150 MG
DESCRIPTION Olanib (Olaparib) Olanib is used for the returning treatment of some types of ovarian cancer in patients who have
OLANIB 50 MG
DESCRIPTION Olanib (Olaparib) Olanib is used for the returning treatment of some types of ovarian cancer in patients who have
OSICENT 80 MG
DESCRIPTION Indications Osimertinib is indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small
OSIMERT 80 MG
DESCRIPTION Osimert 80 mg Osimertinib COMPOSITION Osimert Tablet: Each film coated tablet contains Osimertinib mesylate INN 95.4 mg equivalent to
PALBOCENT 125 MG
DESCRIPTION Palbocent Palbociclib 125 mg Capsules Incepta Pharmaceuticals Limited Indications Palbociclib is a kinase inhibitor indicated for the treatment of
PALBONIX 125 MG
DESCRIPTION Product Description: Palbociclib is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with: